137 related articles for article (PubMed ID: 17440090)
1. Mechanism of action of the microtubule-targeted antimitotic depsipeptide tasidotin (formerly ILX651) and its major metabolite tasidotin C-carboxylate.
Ray A; Okouneva T; Manna T; Miller HP; Schmid S; Arthaud L; Luduena R; Jordan MA; Wilson L
Cancer Res; 2007 Apr; 67(8):3767-76. PubMed ID: 17440090
[TBL] [Abstract][Full Text] [Related]
2. Stathmin family protein SCG10 differentially regulates the plus and minus end dynamics of microtubules at steady state in vitro: implications for its role in neurite outgrowth.
Manna T; Grenningloh G; Miller HP; Wilson L
Biochemistry; 2007 Mar; 46(11):3543-52. PubMed ID: 17311410
[TBL] [Abstract][Full Text] [Related]
3. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action.
Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D
Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873
[TBL] [Abstract][Full Text] [Related]
4. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
[TBL] [Abstract][Full Text] [Related]
5. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism.
Derry WB; Wilson L; Jordan MA
Cancer Res; 1998 Mar; 58(6):1177-84. PubMed ID: 9515803
[TBL] [Abstract][Full Text] [Related]
6. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
Honore S; Kamath K; Braguer D; Horwitz SB; Wilson L; Briand C; Jordan MA
Cancer Res; 2004 Jul; 64(14):4957-64. PubMed ID: 15256469
[TBL] [Abstract][Full Text] [Related]
7. Intracellular activation and deactivation of tasidotin, an analog of dolastatin 15: correlation with cytotoxicity.
Bai R; Edler MC; Bonate PL; Copeland TD; Pettit GR; Ludueña RF; Hamel E
Mol Pharmacol; 2009 Jan; 75(1):218-26. PubMed ID: 18927208
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics in mice implanted with xenografted tumors after intravenous administration of tasidotin (ILX651) or its carboxylate metabolite.
Bonate PL; Beyerlein D; Crawford J; Roth S; Krumbholz R; Schmid S
AAPS J; 2007 Dec; 9(3):E378-87. PubMed ID: 18170985
[TBL] [Abstract][Full Text] [Related]
9. Antimitotic sulfonamides inhibit microtubule assembly dynamics and cancer cell proliferation.
Mohan R; Banerjee M; Ray A; Manna T; Wilson L; Owa T; Bhattacharyya B; Panda D
Biochemistry; 2006 May; 45(17):5440-9. PubMed ID: 16634625
[TBL] [Abstract][Full Text] [Related]
10. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest.
Kamath K; Jordan MA
Cancer Res; 2003 Sep; 63(18):6026-31. PubMed ID: 14522931
[TBL] [Abstract][Full Text] [Related]
11. Kinetic stabilization of microtubule dynamics by estramustine is associated with tubulin acetylation, spindle abnormalities, and mitotic arrest.
Mohan R; Panda D
Cancer Res; 2008 Aug; 68(15):6181-9. PubMed ID: 18676841
[TBL] [Abstract][Full Text] [Related]
12. Kinetic stabilization of microtubule dynamic instability by benomyl increases the nuclear transport of p53.
Rathinasamy K; Panda D
Biochem Pharmacol; 2008 Dec; 76(12):1669-80. PubMed ID: 18823952
[TBL] [Abstract][Full Text] [Related]
13. The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth.
Jordan MA; Kamath K; Manna T; Okouneva T; Miller HP; Davis C; Littlefield BA; Wilson L
Mol Cancer Ther; 2005 Jul; 4(7):1086-95. PubMed ID: 16020666
[TBL] [Abstract][Full Text] [Related]
14. Regulation of microtubule dynamics in 3T3 fibroblasts by Rho family GTPases.
Grigoriev I; Borisy G; Vorobjev I
Cell Motil Cytoskeleton; 2006 Jan; 63(1):29-40. PubMed ID: 16362953
[TBL] [Abstract][Full Text] [Related]
15. 2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules.
Kamath K; Okouneva T; Larson G; Panda D; Wilson L; Jordan MA
Mol Cancer Ther; 2006 Sep; 5(9):2225-33. PubMed ID: 16985056
[TBL] [Abstract][Full Text] [Related]
16. Analysis of dynamic instability of steady-state microtubules in vitro by video-enhanced differential interference contrast microscopy with an appendix by Emin Oroudjev.
Yenjerla M; Lopus M; Wilson L
Methods Cell Biol; 2010; 95():189-206. PubMed ID: 20466136
[TBL] [Abstract][Full Text] [Related]
17. Dicoumarol: a unique microtubule stabilizing natural product that is synergistic with Taxol.
Madari H; Panda D; Wilson L; Jacobs RS
Cancer Res; 2003 Mar; 63(6):1214-20. PubMed ID: 12649179
[TBL] [Abstract][Full Text] [Related]
18. Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primates.
Kilburn LB; Bonate PL; Blaney SM; McGuffey L; Nuchtern JG; Dauser R; Thompson P; Gibson BW; Berg SL
Cancer Chemother Pharmacol; 2009 Jul; 64(2):335-40. PubMed ID: 19043710
[TBL] [Abstract][Full Text] [Related]
19. LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis.
de Arruda M; Cocchiaro CA; Nelson CM; Grinnell CM; Janssen B; Haupt A; Barlozzari T
Cancer Res; 1995 Jul; 55(14):3085-92. PubMed ID: 7606731
[TBL] [Abstract][Full Text] [Related]
20. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules.
Ngan VK; Bellman K; Panda D; Hill BT; Jordan MA; Wilson L
Cancer Res; 2000 Sep; 60(18):5045-51. PubMed ID: 11016627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
